LOS ANGELES, CA--(MARKET WIRE)--Aug 21, 2008 -- Universal Detection Technology (www.udetection.com) (OTC BB:UNDT.OB - News) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order for its anti-microbial washing machine additive from NovaMed. NovaMed plans to use the product to disinfect clothing and linen at its ambulatory surgery centers. UDT's Anti-microbial washing machine additive is effective in sterilizing fabrics and linen from harmful bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA).

MRSA is found worldwide, predominantly in hospitals and institutions such as nursing homes. Recently MRSA has also spread in the general community. There are three main reservoirs (and hence sources of spread and infection) for MRSA in hospital and institutions: staff, patients and inanimate objects such as beds, linen and utensils. Hospitals need to take precautions to prevent the spread of MRSA by sterilizing linen and clothing.

MRSA infections occur in approximately 94,000 persons each year and are associated with approximately 19,000 deaths. Of these infections, about 86% are healthcare-associated and 14% are community-associated.

"The purchase order from NovaMed comes as another milestone for our company as more companies and individuals discover the unique sterilization capabilities of our anti-microbial products," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer.

For more information please visit our website at www.udetection.com or

Email us at info@udetection.com.

About NovaMed

NovaMed's focus is on the acquisition, development and management of ambulatory surgery centers (ASCs) to provide the best possible experience and outcome for physicians and patients. NovaMed has the resources of a national company, yet is small enough to let clients deal directly with decision makers. NovaMed was founded in 1995 and went public in 1999. For more information on NovaMed please visit www.novamed.com.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

     Contact:
     Jacques Tizabi
     310-248-3655
     Email Contact